Inogen (INGN) EBIT Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.36% |
| Dec 31, 2025 | -11.00% |
| Sep 30, 2025 | -29.25% |
| Jun 30, 2025 | -21.12% |
| Mar 31, 2025 | -28.57% |
| Dec 31, 2024 | -16.43% |
| Sep 30, 2024 | -24.25% |
| Jun 30, 2024 | -20.89% |
| Mar 31, 2024 | -39.85% |
| Dec 31, 2023 | -51.83% |
| Sep 30, 2023 | -45.38% |
| Jun 30, 2023 | -23.21% |
| Mar 31, 2023 | -35.21% |
| Dec 31, 2022 | -67.71% |
| Sep 30, 2022 | -26.47% |
| Jun 30, 2022 | -18.52% |
| Mar 31, 2022 | -34.73% |
| Dec 31, 2021 | -25.24% |
| Sep 30, 2021 | 3.38% |
| Jun 30, 2021 | 7.79% |
| Mar 31, 2021 | -21.53% |
| Dec 31, 2020 | -29.12% |
| Sep 30, 2020 | -20.41% |
| Jun 30, 2020 | -19.53% |
| Mar 31, 2020 | -23.43% |
| Dec 31, 2019 | -41.71% |
| Sep 30, 2019 | 17.85% |
| Jun 30, 2019 | 25.11% |
| Mar 31, 2019 | 25.68% |
| Dec 31, 2018 | 53.90% |
| Sep 30, 2018 | 63.64% |
| Jun 30, 2018 | 42.43% |
| Mar 31, 2018 | 68.90% |